Neuvotion was founded by Chad Bouton, a professor at the Feinstein Institutes for Medical Research at Northwell Health. The startup plans to use the funding to grow its staff, complete clinical trials, and get FDA clearance for its first product.
“Neuvotion’s noninvasive AI-based technology has the potential to revolutionize rehabilitation for patients who are suffering from movement impairment,” said Milind Parate, who leads Northwell Holdings‘ ventures portfolio, in an April 13 news release. “We look forward to supporting the work of the Neuvotion team as they develop this novel technology and assess its efficacy in addressing this significant challenge.”
The early-stage company plans to start a multisite clinical study this year.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
